Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000731588 | SCV000859428 | uncertain significance | not provided | 2018-01-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000731588 | SCV000977921 | likely benign | not provided | 2018-03-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001511690 | SCV001718974 | benign | Charcot-Marie-Tooth disease type 2 | 2023-07-17 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000731588 | SCV003816990 | likely benign | not provided | 2023-11-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003947934 | SCV004761731 | likely benign | LMNA-related condition | 2021-05-05 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV001700299 | SCV001927002 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001700299 | SCV001957480 | benign | not specified | no assertion criteria provided | clinical testing |